Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
British Journal of Haematology|June 16, 2023
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort studyJoshua P Entrop, Caroline E Weibull, Karin E Smedby, et al.Nature Communications|November 14, 2025
scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samplesRam Prakash Yadav, Pengwei Xing, Miao Zhao, et al.Blood Advances|May 22, 2025
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell LymphomaLeo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, et al.Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.British Journal of Haematology|April 30, 2024
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort studyJulie Haugaard Vandtved, Andreas Kiesbye Øvlisen, Joachim Baech, et al.Blood Advances|December 19, 2023
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trialMats Jerkeman, Arne Kolstad, Martin Hutchings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group StudyJorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta, et al.European Urology Oncology|September 12, 2019
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer GroupAxel Gerdtsson, Ulf Håkansson, Magnus Törnblom, et al.British Journal of Haematology|October 16, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapyIngemar Lagerlöf, Harald Holte, Ingrid Glimelius, et al.Journal of the National Cancer Institute|February 7, 2002
Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis, Mary Gospodarowicz, Rochelle E Curtis, et al.Pageof 12